An investigation of seven other publications by the first author of a retracted paper due to doubts about data integrity
Autor: | Lyle C. Gurrin, Jim G Thornton, Ben W.J. Mol, Esmée M Bordewijk, Madelon van Wely, Wentao Li |
---|---|
Přispěvatelé: | Graduate School, Amsterdam Reproduction & Development (AR&D), Center for Reproductive Medicine, APH - Methodology, APH - Personalized Medicine |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Scientific Misconduct Randomization law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Data integrity medicine Humans Medical physics 030212 general & internal medicine Baseline (configuration management) Scientific misconduct 030219 obstetrics & reproductive medicine business.industry Research integrity Obstetrics and Gynecology Retraction Test (assessment) Reproductive Medicine Baseline characteristics business |
Zdroj: | European Journal of Obstetrics and Gynecology and Reproductive Biology, 261, 236-241. Elsevier Ireland Ltd |
ISSN: | 0301-2115 |
DOI: | 10.1016/j.ejogrb.2021.04.018 |
Popis: | Background In 2019, a randomized controlled trial (RCT) authored by Dr. Ismail was retracted due to concerns about data integrity. Since there are no policies in place to investigate other publications of authors of retracted studies, we investigated Dr. Ismail’s other trials. Methods We searched for RCTs authored by Dr. Ismail. We made pairwise comparisons of values in baseline and outcome tables between trials. We assessed whether the distributions of baseline characteristics were compatible with properly conducted randomization, using Monte Carlo simulations and the Kolmogorov-Smirnov test. We read the publications carefully for unusual features. Results Dr. Ismail was author in eight published and one unpublished trial. In three of his first author studies we found multiple identical values in the baseline and/or outcome tables from different trials. At least some of the trials were unlikely to have followed a proper randomization process. There were a number of other unusual features in the papers we reviewed. Conclusions It is probable that other trials published by Dr. Ismail contain questionable data. We call for a thorough investigation of the original trial data and related official documents. Our exercise suggests that the practice to assess research integrity should include all publications of authors with retracted fabricated articles. |
Databáze: | OpenAIRE |
Externí odkaz: |